{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:04Z","timestamp":1707525064859},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,24]]},"DOI":"10.7759\/cureus.40889","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:26:07Z","timestamp":1687605967000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Review of Vagal Nerve Stimulation Versus Baroreceptor Activation Therapy in Cardiac Diseases"],"prefix":"10.7759","author":[{"given":"Akshat V","family":"Arya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshi","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apoorva","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manali","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwati","family":"Konat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalika","family":"Mozumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhrumil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devansh","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suac036","article-title":"Neuromodulation devices for heart failure","volume":"24","author":"Dusi V","year":"2022","unstructured":"Dusi V, Angelini F, Zile MR, De Ferrari GM. Neuromodulation devices for heart failure. Eur Heart J Suppl. 2022, 24:12-27. 10.1093\/eurheartjsupp\/suac036","journal-title":"Eur Heart J Suppl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suac031","article-title":"Current and future use of neuromodulation in heart failure","volume":"24","author":"Duncker D","year":"2022","unstructured":"Duncker D, Bauersachs J. Current and future use of neuromodulation in heart failure. Eur Heart J Suppl. 2022, 24:28-34. 10.1093\/eurheartjsupp\/suac031","journal-title":"Eur Heart J Suppl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.05.008","article-title":"Novel interventional therapies to modulate the autonomic tone in heart failure","volume":"3","author":"Chatterjee NA","year":"2015","unstructured":"Chatterjee NA, Singh JP. Novel interventional therapies to modulate the autonomic tone in heart failure. JACC Heart Fail. 2015, 3:786-802. 10.1016\/j.jchf.2015.05.008","journal-title":"JACC Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2016.03.004","article-title":"Neuromodulation of the failing heart: lost in translation?","volume":"1","author":"Byku M","year":"2016","unstructured":"Byku M, Mann DL. Neuromodulation of the failing heart: lost in translation?. JACC Basic Transl Sci. 2016, 1:95-106. 10.1016\/j.jacbts.2016.03.004","journal-title":"JACC Basic Transl Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14190","article-title":"Baroreflex activation therapy in advanced heart failure therapy: insights from a real-world scenario","volume":"10","author":"Guckel D","year":"2023","unstructured":"Guckel D, Eitz T, El Hamriti M, et al.. Baroreflex activation therapy in advanced heart failure therapy: insights from a real-world scenario. ESC Heart Fail. 2023, 10:284-94. 10.1002\/ehf2.14190","journal-title":"ESC Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2020.10.003","article-title":"Vagus nerve stimulation provides multiyear improvements in autonomic function and cardiac electrical stability in the ANTHEM-HF study","volume":"27","author":"Nearing BD","year":"2021","unstructured":"Nearing BD, Anand IS, Libbus I, Dicarlo LA, Kenknight BH, Verrier RL. Vagus nerve stimulation provides multiyear improvements in autonomic function and cardiac electrical stability in the ANTHEM-HF study. J Card Fail. 2021, 27:208-16. 10.1016\/j.cardfail.2020.10.003","journal-title":"J Card Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.857538","article-title":"Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure","volume":"13","author":"Konstam MA","year":"2022","unstructured":"Konstam MA, Mann DL, Udelson JJ, et al.. Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure. Front Physiol. 2022, 13:857538. 10.3389\/fphys.2022.857538","journal-title":"Front Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00183.2004","article-title":"Cardiac neuronal hierarchy in health and disease","volume":"287","author":"Armour JA","year":"2004","unstructured":"Armour JA. Cardiac neuronal hierarchy in health and disease. Am J Physiol Regul Integr Comp Physiol. 2004, 287:262-71. 10.1152\/ajpregu.00183.2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.061","article-title":"Sympathetic nervous system activation in human heart failure: clinical implications of an updated model","volume":"54","author":"Floras JS","year":"2009","unstructured":"Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009, 54:375-85. 10.1016\/j.jacc.2009.03.061","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-109780351-1","article-title":"Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death","volume":"16","author":"Hull SS Jr","year":"1990","unstructured":"Hull SS Jr, Evans AR, Vanoli E, et al.. Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death. J Am Coll Cardiol. 1990, 16:978-85. 10.1016\/s0735-109780351-1","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.16.2072","article-title":"Autonomic tone and reflexes after myocardial infarcton. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials","volume":"103","author":"La Rovere MT","year":"2001","unstructured":"La Rovere MT, Pinna GD, Hohnloser SH, et al.. Autonomic tone and reflexes after myocardial infarcton. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001, 103:2072-7. 10.1161\/01.cir.103.16.2072","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2018.20.2","article-title":"Calming the nervous heart: autonomic therapies in heart failure","volume":"4","author":"Hanna P","year":"2018","unstructured":"Hanna P, Shivkumar K, Ardell JL. Calming the nervous heart: autonomic therapies in heart failure. Card Fail Rev. 2018, 4:92-8. 10.15420\/cfr.2018.20.2","journal-title":"Card Fail Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1113\/JP271165","article-title":"Myocardial infarction induces structural and functional remodelling of the intrinsic cardiac nervous system","volume":"594","author":"Rajendran PS","year":"2016","unstructured":"Rajendran PS, Nakamura K, Ajijola OA, Vaseghi M, Armour JA, Ardell JL, Shivkumar K. Myocardial infarction induces structural and functional remodelling of the intrinsic cardiac nervous system. J Physiol. 2016, 594:321-41. 10.1113\/JP271165","journal-title":"J Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94715","article-title":"Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm","volume":"2","author":"Ajijola OA","year":"2017","unstructured":"Ajijola OA, Hoover DB, Simerly TM, et al.. Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm. JCI Insight. 2017, 2:e94715. 10.1172\/jci.insight.94715","journal-title":"JCI Insight"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98694","article-title":"Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity","volume":"3","author":"Liu K","year":"2018","unstructured":"Liu K, Li D, Hao G, et al.. Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity. JCI Insight. 2018, 3:e98694. 10.1172\/jci.insight.98694","journal-title":"JCI Insight"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1113\/JP271870","article-title":"Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics","volume":"594","author":"Shivkumar K","year":"2016","unstructured":"Shivkumar K, Ajijola OA, Anand I, et al.. Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol. 2016, 594:3911-54. 10.1113\/JP271870","journal-title":"J Physiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1113\/JP271869","article-title":"Translational neurocardiology: preclinical models and cardioneural integrative aspects","volume":"594","author":"Ardell JL","year":"2016","unstructured":"Ardell JL, Andresen MC, Armour JA, et al.. Translational neurocardiology: preclinical models and cardioneural integrative aspects. J Physiol. 2016, 594:3877-909. 10.1113\/JP271869","journal-title":"J Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03699","article-title":"Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure","volume":"64","author":"Wang HJ","year":"2014","unstructured":"Wang HJ, Wang W, Cornish KG, Rozanski GJ, Zucker IH. Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure. Hypertension. 2014, 64:745-55. 10.1161\/HYPERTENSIONAHA.114.03699","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2011.08.007","article-title":"Neurohumoral stimulation","volume":"8","author":"Zucker IH","year":"2012","unstructured":"Zucker IH, Patel KP, Schultz HD. Neurohumoral stimulation. Heart Fail Clin. 2012, 8:87-99. 10.1016\/j.hfc.2011.08.007","journal-title":"Heart Fail Clin"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90899-v","article-title":"Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation","volume":"15","author":"Marin-Neto JA","year":"1991","unstructured":"Marin-Neto JA, Pintya AO, Gallo J\u00fanior L, et al.. Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation. Am J Cardiol. 1991, 15:604-10. 10.1016\/0002-9149(91)90899-v","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034173","article-title":"Vagus nerve stimulation and the cardiovascular system","volume":"10","author":"Capilupi MJ","year":"2020","unstructured":"Capilupi MJ, Kerath SM, Becker LB. Vagus nerve stimulation and the cardiovascular system. Cold Spring Harb Perspect Med. 2020, 10:a034173. 10.1101\/cshperspect.a034173","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal A","year":"2001","unstructured":"Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001, 103:2055-9. 10.1161\/01.cir.103.16.2055","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.68.5.1471","article-title":"Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction","volume":"68","author":"Vanoli E","year":"1991","unstructured":"Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991, 68:1471-81. 10.1161\/01.res.68.5.1471","journal-title":"Circ Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq391","article-title":"Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure","volume":"32","author":"De Ferrari GM","year":"2011","unstructured":"De Ferrari GM, Crijns HJ, Borggrefe M, et al.. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011, 32:847-55. 10.1093\/eurheartj\/ehq391","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00490.2007","article-title":"Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit","volume":"293","author":"Uemura K","year":"2007","unstructured":"Uemura K, Li M, Tsutsumi T, et al.. Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit. Am J Physiol Heart Circ Physiol. 2007, 293:2254-61. 10.1152\/ajpheart.00490.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the\u00a0management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the\u00a0management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017, 70:776-803. 10.1016\/j.jacc.2017.04.025","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.855756","article-title":"Multifactorial benefits of chronic vagus nerve stimulation on autonomic function and cardiac electrical stability in heart failure patients with reduced ejection fraction","volume":"13","author":"Verrier RL","year":"2022","unstructured":"Verrier RL, Libbus I, Nearing BD, KenKnight BH. Multifactorial benefits of chronic vagus nerve stimulation on autonomic function and cardiac electrical stability in heart failure patients with reduced ejection fraction. Front Physiol. 2022, 13:855756. 10.3389\/fphys.2022.855756","journal-title":"Front Physiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12592","article-title":"Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF","volume":"7","author":"Anand IS","year":"2020","unstructured":"Anand IS, Konstam MA, Klein HU, et al.. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020, 7:75-83. 10.1002\/ehf2.12592","journal-title":"ESC Heart Fail"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-021-05076-5","article-title":"Vagal stimulation in heart failure","volume":"46","author":"Dusi V","year":"2021","unstructured":"Dusi V, De Ferrari GM. Vagal stimulation in heart failure. Herz. 2021, 46:541-9. 10.1007\/s00059-021-05076-5","journal-title":"Herz"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.08.009","article-title":"Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial","volume":"20","author":"Premchand RK","year":"2014","unstructured":"Premchand RK, Sharma K, Mittal S, et al.. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail. 2014, 20:808-16. 10.1016\/j.cardfail.2014.08.009","journal-title":"J Card Fail"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)31407-8","article-title":"Effects of sympathetic blockade on responsiveness to VNS in patients with heart failure and reduced ejection fraction","volume":"75","author":"Anand I","year":"2020","unstructured":"Anand I, Ardell J, Gregory D, et al.. Effects of sympathetic blockade on responsiveness to VNS in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2020, 75:780. 10.1016\/S0735-1097(20)31407-8","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1113\/JP274678","article-title":"Defining the neural fulcrum for chronic vagus nerve stimulation: implications for integrated cardiac control","volume":"595","author":"Ardell JL","year":"2017","unstructured":"Ardell JL, Nier H, Hammer M, et al.. Defining the neural fulcrum for chronic vagus nerve stimulation: implications for integrated cardiac control. J Physiol. 2017, 595:6887-903. 10.1113\/JP274678","journal-title":"J Physiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-200109000-00005","article-title":"Vagus nerve stimulation, side effects, and long-term safety","volume":"18","author":"Ben-Menachem E","year":"2001","unstructured":"Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol. 2001, 18:415-8. 10.1097\/00004691-200109000-00005","journal-title":"J Clin Neurophysiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.01.006","article-title":"Vagus nerve stimulation and late-onset bradycardia and asystole: case report","volume":"26","author":"Pascual FT","year":"2015","unstructured":"Pascual FT. Vagus nerve stimulation and late-onset bradycardia and asystole: case report. Seizure. 2015, 26:5-6. 10.1016\/j.seizure.2015.01.006","journal-title":"Seizure"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000544","article-title":"Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction","volume":"18","author":"Gronda E","year":"2017","unstructured":"Gronda E, Francis D, Zannad F, Hamm C, Brugada J, Vanoli E. Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction. J Cardiovasc Med (Hagerstown). 2017, 18:641-9. 10.2459\/JCM.0000000000000544","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-01958-y","article-title":"Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States","volume":"21","author":"Bisognano J","year":"2021","unstructured":"Bisognano J, Schneider JE, Davies S, et al.. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States. BMC Cardiovasc Disord. 2021, 21:155. 10.1186\/s12872-021-01958-y","journal-title":"BMC Cardiovasc Disord"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham WT","year":"2002","unstructured":"Abraham WT, Fisher WG, Smith AL, et al.. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002, 346:1845-53. 10.1056\/NEJMoa013168","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-019-0422-3","article-title":"Cardiac contractility modulation and baroreflex activation therapy in heart failure patients","volume":"16","author":"Mann JA","year":"2019","unstructured":"Mann JA, Abraham WT. Cardiac contractility modulation and baroreflex activation therapy in heart failure patients. Curr Heart Fail Rep. 2019, 16:38-46. 10.1007\/s11897-019-0422-3","journal-title":"Curr Heart Fail Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart\u00a0failure with reduced ejection fraction","volume":"76","author":"Zile MR","year":"2020","unstructured":"Zile MR, Lindenfeld J, Weaver FA, Zannad F, Galle E, Rogers T, Abraham WT. Baroreflex activation therapy in patients with heart\u00a0failure with reduced ejection fraction. J Am Coll Cardiol. 2020, 76:1-13. 10.1016\/j.jacc.2020.05.015","journal-title":"J Am Coll Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.328","article-title":"Baroreceptor activation therapy: the importance of targeting the right patient: who needs to be treated?","volume":"17","author":"Mortara A","year":"2015","unstructured":"Mortara A, Vanoli E. Baroreceptor activation therapy: the importance of targeting the right patient: who needs to be treated?. Eur J Heart Fail. 2015, 17:1000-2. 10.1002\/ejhf.328","journal-title":"Eur J Heart Fail"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.149","article-title":"Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization","volume":"145","author":"Jain P","year":"2003","unstructured":"Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J. 2003, 145:3-17. 10.1067\/mhj.2003.149","journal-title":"Am Heart J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.001281","article-title":"Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction","volume":"7","author":"Bello NA","year":"2014","unstructured":"Bello NA, Claggett B, Desai AS, et al.. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail. 2014, 7:590-5. 10.1161\/CIRCHEARTFAILURE.113.001281","journal-title":"Circ Heart Fail"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1981.241.5.R286","article-title":"Reflex effects of renal afferents on the heart and kidney","volume":"241","author":"Kostreva DR","year":"1981","unstructured":"Kostreva DR, Seagard JL, Castaner A, Kampine JP. Reflex effects of renal afferents on the heart and kidney. Am J Physiol. 1981, 241:286-92. 10.1152\/ajpregu.1981.241.5.R286","journal-title":"Am J Physiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.138","article-title":"Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study","volume":"16","author":"Gronda E","year":"2014","unstructured":"Gronda E, Seravalle G, Brambilla G, et al.. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail. 2014, 16:977-83. 10.1002\/ejhf.138","journal-title":"Eur J Heart Fail"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000603","article-title":"Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction","volume":"33","author":"Gronda E","year":"2015","unstructured":"Gronda E, Seravalle G, Trevano FQ, et al.. Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction. J Hypertens. 2015, 33:1704-8. 10.1097\/HJH.0000000000000603","journal-title":"J Hypertens"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.02.006","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham WT","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA, et al.. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail. 2015, 3:487-96. 10.1016\/j.jchf.2015.02.006","journal-title":"JACC Heart Fail"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.5114\/kitp.2018.78447","article-title":"Carotid baroreceptor activation therapy for resistant hypertension and heart failure: a report of two cases","volume":"15","author":"Durukan AB","year":"2018","unstructured":"Durukan AB, Gurbuz HA. Carotid baroreceptor activation therapy for resistant hypertension and heart failure: a report of two cases. Pol J Thorac Cardiovasc Surg. 2018, 15:200-3. 10.5114\/kitp.2018.78447","journal-title":"Pol J Thorac Cardiovasc Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12484","article-title":"Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies","volume":"6","author":"Premchand RK","year":"2019","unstructured":"Premchand RK, Sharma K, Mittal S, et al.. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies. ESC Heart Fail. 2019, 6:1052-6. 10.1002\/ehf2.12484","journal-title":"ESC Heart Fail"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.06.036","article-title":"Long-term vagal stimulation for heart failure: eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial","volume":"244","author":"De Ferrari GM","year":"2017","unstructured":"De Ferrari GM, Stolen C, Tuinenburg AE, et al.. Long-term vagal stimulation for heart failure: eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial. Int J Cardiol. 2017, 244:229-34. 10.1016\/j.ijcard.2017.06.036","journal-title":"Int J Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.525","article-title":"Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial","volume":"68","author":"Gold MR","year":"2016","unstructured":"Gold MR, Van Veldhuisen DJ, Hauptman PJ, et al.. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016, 68:149-58. 10.1016\/j.jacc.2016.03.525","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159427-a-comparative-review-of-vagal-nerve-stimulation-versus-baroreceptor-activation-therapy-in-cardiac-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:40Z","timestamp":1707508780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159427-a-comparative-review-of-vagal-nerve-stimulation-versus-baroreceptor-activation-therapy-in-cardiac-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.40889","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,24]]}}}